Michael E. Laska

1.4k citations
7 papers · 1.2k · 2 hit papers · h-index 6

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • RNA Interference and Gene Delivery
    • Protein purification and stability
    • RNA and protein synthesis mechanisms

Papers in

Michael E. Laska

7 papers receiving 1.1k citations

Michael E. Laska's Hit Papers

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials 2019 · 386 citations
3860+3+6Years since publication100200300400500

Peers

Michael E. Laska
Comparison fields: 5 of 63
  • Infectious Diseases 315
  • Molecular Biology 634
  • Immunology 190
  • Epidemiology 181
  • Biomaterials 58
Replace Karnyart Samnuan with:
Karnyart Samnuan United Kingdom
Matthew Pine United States
Cinzia Giovani Italy
Ekaterina Kinnear United Kingdom
Elinor Willis United States
Luisa Accardi Italy
Jann Catherine Ang Canada
Maria Fe C. Medina Canada
Jort Vellinga Netherlands
Isabella Renzi United States
Michael E. Laska relative to Karnyart Samnuan United Kingdom Karnyart Samnuan's profile →
Citations per field
00.5×2×3×4×4.8×
Karnyart Samnuan · 1×
Citations per year

Countries citing papers authored by Michael E. Laska

Since Specialization
Citations

This map shows the geographic impact of Michael E. Laska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Laska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Laska more than expected).

Fields of papers citing papers by Michael E. Laska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Laska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Laska. The network helps show where Michael E. Laska may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Laska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Laska Line = papers co-authored together Michael E. Laska links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Hit paper breakdown →
2017559
2
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Hit paper breakdown →
2019386
3 2017175
4 200539
5 200534
6 202212
7 20051

About Michael E. Laska

Michael E. Laska is a scholar working on Epidemiology, Molecular Biology, Genetics, Water Science and Technology and Nuclear Energy and Engineering, having authored 7 papers that have together received 1.2k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (3 papers), Protein purification and stability (3 papers), Virus-based gene therapy research (2 papers), RNA Interference and Gene Delivery (1 paper) and Membrane Separation Technologies (1 paper). The work is most often cited by research in Infectious Diseases (315 citations), Molecular Biology (634 citations), Immunology (190 citations), Epidemiology (181 citations) and Biomaterials (58 citations). Michael E. Laska has collaborated with scholars based in United States. Frequent co-authors include Mike Smith, James D. Thompson, Tal Z. Zaks, Örn Almarsson, Giuseppe Ciaramella, Joseph J. Senn, Kapil Bahl, Olga Yuzhakov, Kimberly J. Hassett and Luis A. Brito. Their work appears in journals such as Human Gene Therapy, Molecular Therapy, Biotechnology and Bioengineering, Vaccine and Veterinary Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact